Get the Stockscreener App
293.23
4.12%
11.61
After Hours:
293.23
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $293.23, with a volume of 3.12M.
It is up +4.12% in the last 24 hours and up +4.17% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$281.62
Open:
$287
24h Volume:
3.12M
Relative Volume:
1.31
Market Cap:
$112.48B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
33.96
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
+5.87%
1M Performance:
+4.17%
6M Performance:
-14.07%
1Y Performance:
-20.70%
1-Day Range:
$286.55
$293.99
1-Week Range:
$274.50
$293.99
52-Week Range:
$267.00
$392.55
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
293.23 | 112.48B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
104.68 | 181.14B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.45 | 122.09B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.14 | 63.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.10 | 50.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-26 | Initiated | Barclays | Overweight |
| Aug-13-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-28-26 | Resumed | UBS | Buy |
| Jul-09-26 | Initiated | BMO Capital Markets | Outperform |
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell? - Zacks Investment Research
Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance? - Zacks Investment Research
ASML: A Rule Breaker Test of Lasting Leadership - The Motley Fool
China Stretchers and Cots Market Outlook to 2033Ambulance, Emergency, Manual, and Motorized Transport Segments | EMS Investment and Automation Unlock Growth Opportunities - GlobeNewswire Inc.
Australia Stretchers and Cots Market Outlook to 2033Revenue, Volume, Pricing and Company Share Forecast | Segment Growth Opens Investment and Expansion Opportunities - GlobeNewswire Inc.
Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Misses Revenue Estimates - Zacks Investment Research
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp.SYK - GlobeNewswire Inc.
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown? - Zacks Investment Research
Spain General Hospital Supplies Market Report 2026: Revenue, Volume, Pricing and Competitive Analysis (2018-2033) | Hospital Beds, Exam Tables, Exam Room Stools, and More - GlobeNewswire Inc.
GEHC vs. SYK: Which Stock Should Value Investors Buy Now? - Zacks Investment Research
Stryker Agrees to Acquire ZuriMED to Expand Shoulder Repair Portfolio - The Healthcare Technology Report.
Form 4 Stryker Corporation For: 28 September By Investing.com - Investing.com Nigeria
Retired Stryker leader Tim Scannell dies at 62 - MassDevice
Form 4 Stryker Corporation For: 28 September By Investing.com - Investing.com Canada
Stryker Corp. stock outperforms competitors on strong trading day - marketwatch.com
A 109-share employee stock plan transfer leaves Stryker (SYK) CFO holding 3,661 shares directly. - Stock Titan
Stryker Corp Lobbyists, 2021 - OpenSecrets
Is ResMed A Better Way Than Stryker To Own Medical Device Growth? - Yahoo Finance
27,714 Stryker Corporation $SYK Shares Sold by Engineers Gate Manager LP - MarketBeat
ELFA Names James Cress Acting President & CEO - GlobeNewswire Inc.
Canada General Hospital Supplies Market Report 2026: Delivers Revenue, Volume, Pricing and Competitive Insights Through 2033 - GlobeNewswire Inc.
Envestnet Asset Management Inc. Purchases 70,634 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corporation (SYK) Options ChainYahoo Finance - Yahoo! Finance Canada
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp.SYK - PR Newswire
Stryker Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Stryker Corp. stock underperforms Thursday when compared to competitors - marketwatch.com
Under a matrimonial settlement, Stryker (SYK) CFO Wells Preston Wendell transferred shares twice. - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Stryker Corpo - The National Law Review
QRG Capital Management Inc. Decreases Holdings in Stryker Corporation $SYK - MarketBeat
Can Stryker Vehicle Demand Support General Dynamics' Growth? - The Globe and Mail
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS - GlobeNewswire
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - Zacks Investment Research
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - TradingView
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now - TradingView
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now - finance.yahoo.com
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - Zacks Investment Research
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now - Yahoo Finance UK
The Premium On Abbott Laboratories Keeps Growing. So Does The Case For Stryker and Boston Scientific - Trefis
Stryker Corporation $SYK Shares Bought by State Street Corp - MarketBeat
Stryker (SYK) Foot And Ankle Push Keeps Undervalued Narrative In Focus - Yahoo Finance
Stryker (SYK) Expanded Its Foot And Ankle Portfolio - finance.yahoo.com
TD Cowen cuts Stryker stock price target to $298 on margin concerns - Investing.com
Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating - marketscreener.com
Stryker, Fusion Orthopedics introduce new foot & ankle innovations at AOFAS Annual Meeting - Today's Medical Developments
STRYKER CORPORATION : JEFFERIES CUTS TARGET PRICE TO $405 FROM $440 - Bitget
Stryker Corporation (SYK) Stock Analysis: Healthcare Giant Poised For 36% Upside - DirectorsTalk Interviews
Stryker Corporation (SYK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Stryker Corp. stock underperforms Friday when compared to competitors - MarketWatch
Stryker Expands Foot & Ankle Innovation With Prophecy and smartHEX - Yahoo Finance
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Stryker Corp Stock (SYK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | Director |
Aug 19 '26 |
Sale |
340.10 |
50,000 |
17,005,165 |
2,251,375 |
| King Debra | See Remarks |
Aug 18 '26 |
Sale |
336.30 |
826 |
277,787 |
6,210 |
| Debra King | Officer |
Aug 18 '26 |
Proposed Sale |
336.30 |
826 |
277,786 |
0 |
| STRYKER RONDA E | Director |
Aug 18 '26 |
Proposed Sale |
335.00 |
350,000 |
117,250,000 |
0 |
| STRYKER RONDA E | Director |
Aug 18 '26 |
Sale |
335.90 |
300,000 |
100,770,963 |
2,301,375 |
| Fletcher Robert S | Officer |
May 28 '26 |
Proposed Sale |
305.59 |
4,544 |
1,388,601 |
0 |
| Fletcher Robert S | VP, Chief Legal Officer |
May 28 '26 |
Sale |
306.87 |
4,544 |
1,394,409 |
10,582 |
| STRYKER RONDA E | Director |
May 26 '26 |
Sale |
312.23 |
310,000 |
96,792,669 |
1,924,880 |
| STRYKER RONDA E | Director |
May 26 '26 |
Proposed Sale |
313.00 |
310,000 |
97,030,000 |
0 |
| Fink M Kathryn | VP, Chief HR Officer |
May 11 '26 |
Sale |
283.85 |
5,220 |
1,481,671 |
13,137 |
1.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):